NCT07450560 is a clinical trial of proton therapy in Solid Tumor, sponsored by Shuanghu Yuan.

Who is sponsoring NCT07450560?

NCT07450560 is sponsored by Shuanghu Yuan.

What drugs are being tested in NCT07450560?

Interventions in NCT07450560: proton therapy.

What condition does NCT07450560 study?

NCT07450560 studies Solid Tumor.

Is NCT07450560 still recruiting?

NCT07450560 is currently active, enrolled. Last updated 10 March 2026.

Last reviewed 2026-03-10 · How we verify

NCT07450560

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET

Active, enrolled Last updated 10 March 2026

What this trial tests

trial testing proton therapy in Solid Tumor in 30 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 February 2026

Primary endpoint
31 December 2028

31 December 2028

Quick facts

Lead sponsor	Shuanghu Yuan
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 February 2026
Primary completion	31 December 2028
Estimated completion	31 December 2028
Sites	1 location across China

Drugs / interventions tested

proton therapy

Conditions studied

Solid Tumor — all drugs for Solid Tumor →

Sponsor

Shuanghu Yuan

Who can join

Adults 18 to 85, any sex, with Solid Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The energy transport process of proton beams after entering biological tissue is observed online via proton knife fully digital PET. The dynamic changes of the delivered dose and action range of proton beams in biological tissue are analyzed, the proton dose distribution is reconstructed, and the energy and position of the targeted ablation by proton beams are determined, so as to realize in-beam online PET monitoring for proton therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of proton therapy

Trials testing the same drug.

NCT06180434 — Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas · recruiting

Other recruiting trials for Solid Tumor

Currently open trials in the same condition.

NCT07489378 — NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rar · recruiting
NCT07487597 — Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors · EARLY_PHASE1 · recruiting
NCT07382544 — Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss · Phase 1 · recruiting
NCT07466160 — A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07327632 — This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07450560 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shuanghu Yuan
Last refreshed: 10 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07450560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing